Skip to main content

Table 4 Example of a single staging test and its thresholds in the presence of the target condition. The CPG scenario is based on considerations and signals found in our literature search, however, modified for illustrative purposes

From: Designing tailored maintenance strategies for systematic reviews and clinical practice guidelines using the Portfolio Maintenance by Test-Treatment (POMBYTT) framework

 

Clinical healthcare example

GPG maintenance scenario

Target condition

Arterial hypertension is present

(≥ 140/90 mmHg)

The recommendation is outdated

(There was new peer-reviewed scientific evidence published)

Objective

To detect the severity, stage, or status of the prevalent hypertension so that an appropriate management option can be selected

To detect the severity, stage, or status of the prevalent outdatedness so that an appropriate management option can be selected

Staging variable

Magnitude of pressure on artery walls in a free-living setting

Likelihood of potential changes in the strength of the recommendation

Staging test

Ambulatory blood pressure monitoring

Survey among experts

Staging test protocol

The patient receives a blood pressure measuring device to wear over the course of 24 h. The device is programmed to record the blood pressure once every 30 min. Blood pressure measurements are averaged for daytime and nighttime

A survey among experts is performed by using the results from the literature selection. Experts are given the current recommendation and literature, while being asked whether the newly identified literature is likely to change the recommendation’s strength requiring a dichotomous answer (yes/no)

Staging test thresholds

Grade 1: 140–159 mmHg systolic and/or 90–99 mmHg diastolic arterial pressure

Grade 2: 160–179 mmHg systolic and/or 100–109 mmHg diastolic arterial pressure

Grade 3: ≥ 180 mmHg systolic and/or ≥ 110 mmHg diastolic arterial pressure

Very unlikely: 0–20% of the surveyed experts indicated that the new evidence is likely to change the strength of the recommendation when updated

Reasonably unlikely: 20–40% of the surveyed experts indicated that the new evidence is likely to change the strength of the recommendation when updated

Unclear: 40–60% of the surveyed experts indicated that the new evidence is likely to change the strength of the recommendation when updated

Reasonable likely: 60–80% of the surveyed experts indicated that the new evidence is likely to change the strength of the recommendation when updated

Very likely: 80–100% of the surveyed experts indicated that the new evidence is likely to change the strength of the recommendation when updated